| Enteric‐Coated Mycophenolate Sodium is Therapeutically Equivalent to Mycophenolate Mofetil in de novo Renal Transplant Patients M Salvadori, H Holzer, A Mattos, H Sollinger, W Arns, F Oppenheimer, ... American Journal of Transplantation 4 (2), 231-236, 2004 | 383 | 2004 |
| Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction F Diekmann, K Budde, F Oppenheimer, L Fritsche, HH Neumayer, ... American Journal of Transplantation 4 (11), 1869-1875, 2004 | 310 | 2004 |
| Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation L Rostaing, D Cantarovich, G Mourad, K Budde, P Rigotti, C Mariat, ... Transplantation 79 (7), 807-814, 2005 | 306 | 2005 |
| Everolimus with reduced calcineurin inhibitor exposure in renal transplantation J Pascual, SP Berger, O Witzke, H Tedesco, S Mulgaonkar, Y Qazi, ... Journal of the American Society of Nephrology 29 (7), 1979-1991, 2018 | 255 | 2018 |
| Losartan decreases plasma levels of TGF-β1 in transplant patients with chronic allograft nephropathy JM Campistol, P Iñigo, W Jimenez, S Lario, PH Clesca, F Oppenheimer, ... Kidney international 56 (2), 714-719, 1999 | 237 | 1999 |
| COVID‐19 in transplant recipients: the Spanish experience E Coll, M Fernández‐Ruiz, JE Sánchez‐Álvarez, JR Martínez‐Fernández, ... American Journal of Transplantation 21 (5), 1825-1837, 2021 | 214 | 2021 |
| MEMBRANOUS GLOMERULONEPHRITIS ASSOCIATED WITH HEPATITIS C VIRUS INFECTION IN RENAL TRANSPLANT PATIENTS1, 2 JM Morales, J Pascual-Capdevila, JM Campistol, G Fernandez-Zatarain, ... Transplantation 63 (11), 1634-1639, 1997 | 173 | 1997 |
| The impact of donor age on the results of renal transplantation F Oppenheimer, P Aljama, C Asensio Peinado, J Bustamante Bustamante, ... Nephrology Dialysis Transplantation 19 (suppl_3), iii11-iii15, 2004 | 161 | 2004 |
| Effects of losartan and amlodipine on intrarenal hemodynamics and TGF-β1 plasma levels in a crossover trial in renal transplant recipients P Inigo, JM Campistol, S Lario, C Piera, B Campos, M Bescós, ... Journal of the American Society of Nephrology 12 (4), 822-827, 2001 | 156 | 2001 |
| Epidemiology and outcomes of multiple antibiotic–resistant bacterial infection in renal transplantation L Linares, C Cervera, F Cofán, MJ Ricart, N Esforzado, V Torregrosa, ... Transplantation proceedings 39 (7), 2222-2224, 2007 | 148 | 2007 |
| Pharmacokinetics for Once‐ Versus Twice‐Daily Tacrolimus Formulations in De Novo Kidney Transplantation: A Randomized, Open‐Label Trial Z Wlodarczyk, JP Squifflet, M Ostrowski, P Rigotti, S Stefoni, F Citterio, ... American Journal of Transplantation 9 (11), 2505-2513, 2009 | 138 | 2009 |
| Risk factors for graft loss and mortality after renal transplantation according to recipient age: a prospective multicentre study JM Morales, R Marcén, D del Castillo, A Andres, M Gonzalez-Molina, ... Nephrology Dialysis Transplantation 27 (suppl_4), iv39-iv46, 2012 | 129 | 2012 |
| Recommendations for management of Chagas disease in organ and hematopoietic tissue transplantation programs in nonendemic areas MJ Pinazo, B Miranda, C Rodríguez-Villar, J Altclas, MB Serra, ... Transplantation Reviews 25 (3), 91-101, 2011 | 128 | 2011 |
| Two‐year outcomes in de novo renal transplant recipients receiving everolimus‐facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study SP Berger, C Sommerer, O Witzke, H Tedesco, S Chadban, S Mulgaonkar, ... American Journal of Transplantation 19 (11), 3018-3034, 2019 | 125 | 2019 |
| Estimated one-year glomerular filtration rate is the best predictor of long-term graft function following renal transplant M Salvadori, A Rosati, A Bock, J Chapman, B Dussol, L Fritsche, V Kliem, ... Transplantation 81 (2), 202-206, 2006 | 122 | 2006 |
| Impact of antibiotic resistance on the development of recurrent and relapsing symptomatic urinary tract infection in kidney recipients M Bodro, G Sanclemente, I Lipperheide, M Allali, F Marco, J Bosch, ... American Journal of Transplantation 15 (4), 1021-1027, 2015 | 116 | 2015 |
| Long‐term experience with kidney transplantation from hepatitis C‐positive donors into hepatitis C‐positive recipients JM Morales, JM Campistol, B Dominguez‐Gil, A Andrés, N Esforzado, ... American Journal of Transplantation 10 (11), 2453-2462, 2010 | 115 | 2010 |
| Role of transforming growth factor‐β1 in the progression of chronic allograft nephropathy JM Campistol, P Iñigo, S Larios, M Bescos, F Oppenheimer Nephrology Dialysis Transplantation 16 (suppl_1), 114-116, 2001 | 115 | 2001 |
| Complement-activating anti-HLA antibodies in kidney transplantation: allograft gene expression profiling and response to treatment C Lefaucheur, D Viglietti, LG Hidalgo, LE Ratner, SM Bagnasco, I Batal, ... Journal of the American Society of Nephrology 29 (2), 620-635, 2018 | 112 | 2018 |
| The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the … JM Grinyó, H Ekberg, RD Mamelok, F Oppenheimer, J Sánchez-Plumed, ... Nephrology Dialysis Transplantation 24 (7), 2269-2276, 2009 | 112 | 2009 |
